MROP.F Stock Overview
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MicroPort CardioFlow Medtech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.33 |
| 52 Week High | HK$0.33 |
| 52 Week Low | HK$0.26 |
| Beta | 0.60 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 10.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MROP.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 0.04% |
| 1Y | n/a | -2.8% | 20.7% |
Return vs Industry: Insufficient data to determine how MROP.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MROP.F performed against the US Market.
Price Volatility
| MROP.F volatility | |
|---|---|
| MROP.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.3% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MROP.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MROP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 579 | Jeffrey R Lindstrom | www.cardioflowmedtech.com |
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
MicroPort CardioFlow Medtech Corporation Fundamentals Summary
| MROP.F fundamental statistics | |
|---|---|
| Market cap | US$527.42m |
| Earnings (TTM) | -US$69.89m |
| Revenue (TTM) | US$41.36m |
12.8x
P/S Ratio-7.5x
P/E RatioIs MROP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MROP.F income statement (TTM) | |
|---|---|
| Revenue | CN¥302.69m |
| Cost of Revenue | CN¥103.38m |
| Gross Profit | CN¥199.31m |
| Other Expenses | CN¥710.73m |
| Earnings | -CN¥511.42m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 65.85% |
| Net Profit Margin | -168.96% |
| Debt/Equity Ratio | 0% |
How did MROP.F perform over the long term?
See historical performance and comparison